Assessment of functional profile and fatigue in Egyptian patients with active secondary progressive MS

Abstract

Background Current longitudinal real-world data on secondary progressive multiple sclerosis (SPMS) remains limited, as most studies utilize cross-sectional designs that do not combine objective metrics with patient-reported outcomes like fatigue and depression. Therefore, integrating multidimensional assessments over time is essential to accurately capture disease evolution and treatment efficacy. Objectives To longitudinally evaluate clinical, cognitive, and functional progression in Egyptian patients with active SPMS over 12 months. Methods This prospective study included 46 Egyptian patients with active SPMS (69.6% females; mean age 43.5 years; mean disease duration 13.9 years). Patients were evaluated at baseline and followed for 12 months at 6-month intervals using Expanded Disability Status Scale (EDSS), Timed 25-Foot Walk Test (T25FWT), Nine-Hole Peg Test (9HPT), Symbol Digit Modalities Test (SDMT), Modified Fatigue Impact Scale (MFIS), and Beck Depression Inventory (BDI). Results Male sex and earlier multiple sclerosis (MS) onset were associated with earlier SPMS conversion and higher early relapse rates. Over 12 months, EDSS increased significantly, with concomitant worsening in motor performance, fatigue, depression, and cognition. Faster progression was observed in patients with baseline spinal cord involvement and higher relapse frequency. Conclusion Disease progression in SPMS is multidimensional. Integrating functional, cognitive, and patient-reported measures is crucial for comprehensive assessment and early detection of progression.

Thalamic atrophy in active and inactive secondary progressive multiple sclerosis patients: A comparative study
Shadi Bahrami, Neda Ramezani, Mohammad Yazdan Panah +6
Caspian Journal of Internal Medicine1 Sep 2026Peer-reviewedCC BY-NC 4.0Full textGeneral medicinePMC
Plasma biomarker strategies to reduce diagnostic uncertainty in p-tau217–based assessment of CSF amyloid positivity in secondary-care patients with MCI
María Pascual-Lucas, Leticia Sarasa, Noelia Fandos +10
Frontiers in aging neuroscience16 Oct 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC
Chronic lesion expansion persists in secondary progressive multiple sclerosis and is associated with neurodegeneration
S. Klistorner, M. Barnett, A. Klistorner
medRxiv23 Sep 2026PreprintAll rights reservedFull textNeurologymedRxiv
Alcohol use is common in older patients with fall-related fractures: a secondary analysis from a prospective cohort study using PEth as an objective assessment of consumption.
Cecilia Rogmark, Linnea Malmgren, Anna Holmgren +2
Acta orthopaedica19 Oct 2026Peer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMC
Rapidly Progressive Buschke-Löwenstein Tumor Managed With Wide Local Excision and Healing by Secondary Intention: A Case Report and Literature Review.
Sabrina E Chin, Natalia Rojas Castro, Henry J Lujan
Case reports in surgery20 Oct 2026Peer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMC

Cite

BibTeX RIS

BibTeX

@article{salaheldin2026assessment,
  title = {{Assessment of functional profile and fatigue in Egyptian patients with active secondary progressive MS}},
  author = {Soha Ahmed Salaheldin and Mohammed Mahmoud Fouad and Azza Abd EL-Nasser Abd El-Aziz and Magd Fouad Zakaria and Mohamed Ali Abd El-Hafeez},
  journal = {The Egyptian Journal of Neurology, Psychiatry and Neurosurgery},
  year = {2026},
  month = oct,
  doi = {10.1186/s41983-026-01274-2},
  url = {https://doi.org/10.1186/s41983-026-01274-2},
  note = {CC BY},
}

RIS

TY  - JOUR
TI  - Assessment of functional profile and fatigue in Egyptian patients with active secondary progressive MS
AU  - Soha Ahmed Salaheldin
AU  - Mohammed Mahmoud Fouad
AU  - Azza Abd EL-Nasser Abd El-Aziz
AU  - Magd Fouad Zakaria
AU  - Mohamed Ali Abd El-Hafeez
PY  - 2026
DA  - 2026/10/25
JO  - The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
DO  - 10.1186/s41983-026-01274-2
UR  - https://doi.org/10.1186/s41983-026-01274-2
AB  - Background Current longitudinal real-world data on secondary progressive multiple sclerosis (SPMS) remains limited, as most studies utilize cross-sectional designs that do not combine objective metrics with patient-reported outcomes like fatigue and depression. Therefore, integrating multidimensional assessments over time is essential to accurately capture disease evolution and treatment efficacy. Objectives To longitudinally evaluate clinical, cognitive, and functional progression in Egyptian patients with active SPMS over 12 months. Methods This prospective study included 46 Egyptian patients with active SPMS (69.6% females; mean age 43.5 years; mean disease duration 13.9 years). Patients were evaluated at baseline and followed for 12 months at 6-month intervals using Expanded Disability Status Scale (EDSS), Timed 25-Foot Walk Test (T25FWT), Nine-Hole Peg Test (9HPT), Symbol Digit Modalities Test (SDMT), Modified Fatigue Impact Scale (MFIS), and Beck Depression Inventory (BDI). Results Male sex and earlier multiple sclerosis (MS) onset were associated with earlier SPMS conversion and higher early relapse rates. Over 12 months, EDSS increased significantly, with concomitant worsening in motor performance, fatigue, depression, and cognition. Faster progression was observed in patients with baseline spinal cord involvement and higher relapse frequency. Conclusion Disease progression in SPMS is multidimensional. Integrating functional, cognitive, and patient-reported measures is crucial for comprehensive assessment and early detection of progression.
SN  - 1687-8329
SN  - 1110-1083
ER  -

Abstract

Related

Cite